Xconomy | Boston - Business + Technology in the Exponential Economy

Ginkgo BioWorks Tapped for $4.1M Synthetic DNA Effort

Ryan McBride 9/16/09

Boston-based synthetic biology startup Ginkgo BioWorks has been selected as one of two entities to support a Scottish initiative to find better ways to assemble synthetic DNA, according to ITI Life Sciences, which has committed $4.1 million to the effort. ITI Life Sciences is a unit of ITI Scotland, a firm that was formed in 2003 by the government of Scotland to help grow industries in the country such as life sciences, energy, and digital media. Ginkgo BioWorks was launched in 2008 by five MIT scientists and researchers to make the construction of synthetic DNA easier and faster, according to its website.

Ryan McBride is Xconomy's correspondent. You can reach him at rmcbride@xconomy.com, or follow him on Twitter at http://twitter.com/Ryan_McBride.

Comments (1) | Reprints | Share:

Links to This Post

Adam Bluestein › Synthetic Bio Startup Gains a Foothold
9/29/09 10:36 pm

[...] across the Charles, thanks to a $150,000 loan from Boston’s LifeTech initiative. As Xconomy recently reported, the company has been selected as one of two entities to support a $4.1 million initiative to find [...]